Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Genus plc ( (GB:GNS) ).
Genus plc reported a routine change in the shareholding of Jim Low, chief operating officer of its Genus ABS unit and a member of the executive leadership team, following his participation in the company’s International Share Incentive Plan. On 9 April 2026, Low acquired 15 ordinary shares through a purchase on the London Stock Exchange and was granted a further five matching shares at no cost under the same plan.
The transactions modestly increase Low’s equity exposure and further align his interests with those of shareholders, reflecting the company’s ongoing use of share-based incentives for senior management. The disclosure was made in line with U.K. market abuse regulations governing dealings by persons discharging managerial responsibilities in listed companies.
The most recent analyst rating on (GB:GNS) stock is a Buy with a £3350.00 price target. To see the full list of analyst forecasts on Genus plc stock, see the GB:GNS Stock Forecast page.
Spark’s Take on GNS Stock
According to Spark, TipRanks’ AI Analyst, GNS is a Neutral.
Genus plc’s overall stock score is driven by strong corporate events and solid financial performance. However, technical indicators suggest caution due to potential overbought conditions, and the high P/E ratio indicates possible overvaluation.
To see Spark’s full report on GNS stock, click here.
More about Genus plc
Genus plc is a London-listed company operating in the animal genetics and breeding industry through its Genus ABS division. It focuses on providing bovine genetics and related reproductive technologies to livestock producers worldwide, aiming to enhance herd productivity and efficiency for customers in global dairy and beef markets.
Average Trading Volume: 188,195
Technical Sentiment Signal: Buy
Current Market Cap: £1.71B
See more data about GNS stock on TipRanks’ Stock Analysis page.

